Recombinant DNA Advisory Committee - 06/7-8/93 
provide health care coverage for all citizens avoid the problems that arise in 
attempting to design a separate compensation system for patients injured because 
of their participation in medical research. Thus, the RAC supports the inclusion 
in basic universal health care of coverage for injury received through participation 
in approved clinical research. It is the strong desire of the RAC that the NIH 
Director would call this issue to the attention of the individuals formulating the 
President’s health care reform proposal." 
Committee Motion 
A motion was made by Dr. Carmen and seconded by Ms. Meyers to approve the letter. 
The motion passed by a vote of 14 in favor, 0 opposed, and no abstentions. This follow- 
up letter will be forwarded to the NIH Director by Dr. Walters. [Executive Secretary’s 
Note: Dr. Walters, Chair of the RAC, forwarded the follow-up letter to Dr. Healy on 
June 28.] 
XXVIII. ADJOURNMENT 
Dr. Walters adjourned the meeting at 4:45 p.m. on June 8, 1993. 
kelson' A Wivel, M.D. 
Executive Secretary 
I hereby acknowledge that, to the best of my 
knowledge, the foregoing Minutes and Attach- 
ment are accurate and complete. 
Date: 1 j 1 ^3 
LeRoy ft. Walters, Ph.D. 
Chair 
Recombinant DNA Advisory Committee 
National Institutes of Health 
Recombinant DNA Research, Volume 17 
[595] 
